Navigation Links
Trial launched into curry chemical's cancer-fighting properties
Date:5/6/2012

being treated with FOLFOX. The remainder will receive FOLFOX only.

Colin Carroll, a 62-year-old compliance consultant from near Loughborough, agreed to take part in the trial after being diagnosed with advanced bowel cancer in January.

"The diagnosis came as a big shock because I'd had no symptoms apart from some occasional cramps," said Colin.

"I'd had a few tests which had come back clear and I'd just been booked for a CT scan when I was rushed to hospital with a suspected intestinal blockage."

Scans showed Colin had bowel cancer which had spread to his liver and, three days after being admitted to Leicester Royal Infirmary, he underwent an emergency ileostomy to bypass the blockage.

"It's been like a whirlwind," said Colin who will need to undergo chemotherapy until mid-August. "To have something creep up on you like that when you have absolutely no control over it really makes you want to fight back. That's why I had no difficulty in agreeing to take part in the trial.

"I've met some amazing people since January and my treatment on the NHS has been fantastic. The way I see it is that I'm being given the best possible chance so in that sense I feel very fortunate."

Dr Joanna Reynolds, Cancer Research UK's director of centres, said: "The Experimental Cancer Medicine Centres Network supports research into some of the most novel and exciting new anti-cancer therapies, often providing the first insights into their effect on cancer patients. By doing a clinical trial like this we will find out more about the potential benefits of taking large amounts of curcumin, as well as any possible side effects this could have for cancer patients."


'/>"/>

Contact: Ailsa Stevens
44-203-469-8300
University of Leicester
Source:Eurekalert

Page: 1 2

Related biology news :

1. Sentara begins international trial -- open at only 24 US locations
2. 12-month ATLANTA trial data show sustained benefit of Catania Stent
3. First results from hospital trials testing
4. Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
5. New filtering technology has environmental, industrial applications
6. Using water to understand human society, from the industrial revolution to global trade
7. First trial in patients with a potential treatment of the incurable ALS muscle disease
8. In just 5 years, gene discovery to clinical trial of potential treatment
9. Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial
10. Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
11. Review of probiotic trial research finds only Bifantis able to claim efficacy for IBS symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics Agency is ... and prevent counterfeit microcircuits from entering into its supply ... in-house microcircuit anti-counterfeit initiative dubbed DNA marking. The capability ... their reliability throughout the supply chain. The new quality ...
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced ... 2015-2019" report to their offering. ... upcoming in this market is the increasing demand for ... recording of patient data for quick and correct diagnosis ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... for predicting biodiversity than biology",Research published in the May ... about biodiversity and opens up new avenues for predicting ... patterns. In the article, an international group ... in a river system can be accurately predicted with ...
... commerce of ornamental stones has grown all over ... decided solid support to the aesthetics of natural ... Marble is, undoubtedly, the ornamental stone par excellence. ... sculptural works which constitute the most important pieces ...
... the May 2008 Pediatric Academic Societies and Asian Society ... adolescent obesity negatively impacts vascular endothelial function, which relates ... in the U.S. during the past 20 years and ... The incidence of obesity in children is also increasing ...
Cached Biology News:Biodiversity -- it's in the water 2Development of new techniques to understand marble quality and durability 2Study supports reason for concern in childhood and adolescent obesity 2
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics software ... a new partner. STT-Systems has developed an impressive ... with offerings in the optical-motion capture, 3D scanning, and industrial ... unit), iSen, is opening eyes around the world. With no ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)... Mass. , Jan. 22, 2015   GenoSpace , a ... of tools to enable the broad use of genomic, imaging ... announced the appointment of Michelle Munson , CEO of ... director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 ... patient care in critical areas, announced the closing of an ... warrants to purchase up to an aggregate 3,500,000 shares of ... and $.01 per warrant.  The warrants have a per share ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... - Combined Company Will Have Three Oncology Products in Clinic -, - Lead Candidate ... ... Wednesday, May 28th, at 11:00 a.m. Pacific ... Time -, BOTHELL, WA and ...
... A new study into the potential health hazards ... predicts that the molecules are easily absorbed into ... the molecules could be toxic to humans and ... Calgary biochemist Peter Tieleman, post-doctoral fellow Luca Monticelli ...
... Income Up 132% Year-Over-Year, SHANGHAI, China, May ... WX ), a leading pharmaceutical, biotechnology and medical ... China and,the United States, today announced its selected ... 31, 2008., (Logo: ...
Cached Biology Technology:Sonus Pharmaceuticals and OncoGenex Technologies to Merge 2Sonus Pharmaceuticals and OncoGenex Technologies to Merge 3Sonus Pharmaceuticals and OncoGenex Technologies to Merge 4Sonus Pharmaceuticals and OncoGenex Technologies to Merge 5Sonus Pharmaceuticals and OncoGenex Technologies to Merge 6Sonus Pharmaceuticals and OncoGenex Technologies to Merge 7Sonus Pharmaceuticals and OncoGenex Technologies to Merge 8How buckyballs hurt cells 2WuXi PharmaTech Announces First Quarter 2008 Results 2WuXi PharmaTech Announces First Quarter 2008 Results 3WuXi PharmaTech Announces First Quarter 2008 Results 4WuXi PharmaTech Announces First Quarter 2008 Results 5WuXi PharmaTech Announces First Quarter 2008 Results 6WuXi PharmaTech Announces First Quarter 2008 Results 7WuXi PharmaTech Announces First Quarter 2008 Results 8WuXi PharmaTech Announces First Quarter 2008 Results 9WuXi PharmaTech Announces First Quarter 2008 Results 10WuXi PharmaTech Announces First Quarter 2008 Results 11
... is extensively scrutinized, including negative ... All horses are of U.S. ... are controlled and documented to ... Pricing: $12/unit for ...
jub, ajuba homolog (Xenopus laevis)...
Prepared in distilled water....
in vitro Translation, Accessory Products...
Biology Products: